Recently, it was reported that kurarinone activated Nrf2 by downregulation of the expression of KEAP1, leading to the expression of antioxidant enzymes, including HO-1 in human prostate cancer cells [39]. The gene discussed is KEAP1; the disease is prostate carcinoma.